title: Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
authors.forename: G
authors.initials: G
authors.lastname: Piccolo
authors.forename: D
authors.initials: D
authors.lastname: Franciotta
authors.forename: M
authors.initials: M
authors.lastname: Versino
authors.forename: E
authors.initials: E
authors.lastname: Alfonsi
authors.forename: M
authors.initials: M
authors.lastname: Lombardi
authors.forename: G
authors.initials: G
authors.lastname: Poma
mesh_terms: D001327:Autoimmune Diseases / Q000139:chemically induced*; D004172:Diplopia / Q000139:chemically induced*; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced*
chemical_list: D016898:Interferon-alpha